Anders Tunek

2.0k total citations
42 papers, 1.7k citations indexed

About

Anders Tunek is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Anders Tunek has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pharmacology and 11 papers in Cancer Research. Recurrent topics in Anders Tunek's work include Pharmacogenetics and Drug Metabolism (13 papers), Carcinogens and Genotoxicity Assessment (11 papers) and Sulfur Compounds in Biology (6 papers). Anders Tunek is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Carcinogens and Genotoxicity Assessment (11 papers) and Sulfur Compounds in Biology (6 papers). Anders Tunek collaborates with scholars based in Sweden, United Kingdom and Australia. Anders Tunek's co-authors include Franz Oesch, Karin Sjödin, Karl L. Platt, Tor Olofsson, Ralph Brattsand, Anders Hallberg, Maths Berlin, Michael Przybylski, P. Bentley and Hans Tegner and has published in prestigious journals such as Journal of Medicinal Chemistry, European Respiratory Journal and Biochemical Pharmacology.

In The Last Decade

Anders Tunek

41 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Tunek Sweden 23 465 430 388 333 226 42 1.7k
H.P. Witschi United States 20 408 0.9× 274 0.6× 115 0.3× 287 0.9× 181 0.8× 43 1.5k
K. Sree Kumar United States 30 673 1.4× 293 0.7× 207 0.5× 244 0.7× 80 0.4× 58 2.1k
Anne P. Autor United States 23 785 1.7× 268 0.6× 213 0.5× 81 0.2× 161 0.7× 43 2.0k
H Bartsch France 18 568 1.2× 117 0.3× 157 0.4× 450 1.4× 140 0.6× 31 1.4k
Manfred Kiese Germany 25 561 1.2× 148 0.3× 253 0.7× 181 0.5× 465 2.1× 114 1.9k
Cheryl L. Zimmerman United States 20 581 1.2× 95 0.2× 335 0.9× 163 0.5× 103 0.5× 63 1.4k
Shobha A. Akerkar United States 17 627 1.3× 78 0.2× 307 0.8× 336 1.0× 107 0.5× 18 1.2k
Gisela Witz United States 23 527 1.1× 121 0.3× 132 0.3× 386 1.2× 63 0.3× 61 1.5k
Cristina Schmitt Gregolin Brazil 16 982 2.1× 282 0.7× 283 0.7× 244 0.7× 34 0.2× 33 2.1k
Hiroshi Ohshima France 19 661 1.4× 122 0.3× 324 0.8× 197 0.6× 39 0.2× 28 1.6k

Countries citing papers authored by Anders Tunek

Since Specialization
Citations

This map shows the geographic impact of Anders Tunek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Tunek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Tunek more than expected).

Fields of papers citing papers by Anders Tunek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Tunek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Tunek. The network helps show where Anders Tunek may publish in the future.

Co-authorship network of co-authors of Anders Tunek

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Tunek. A scholar is included among the top collaborators of Anders Tunek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Tunek. Anders Tunek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ballard, Peter, Patrick Brassil, Khanh Bui, et al.. (2012). The right compound in the right assay at the right time: an integrated discovery DMPK strategy. Drug Metabolism Reviews. 44(3). 224–252. 37 indexed citations
3.
Ekberg‐Jansson, Ann, et al.. (1999). N‐isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis. European Respiratory Journal. 13(4). 829–829. 25 indexed citations
4.
Sjödin, Karin, et al.. (1998). Synthesis and Enzymatic Hydrolysis of Esters, Constituting Simple Models of Soft Drugs.. Chemical and Pharmaceutical Bulletin. 46(4). 591–601. 35 indexed citations
5.
Wieslander, Elisabet, et al.. (1998). Pharmacologic Importance of the Reversible Fatty Acid Conjugation of Budesonide Studied in a Rat Cell Line In Vitro. American Journal of Respiratory Cell and Molecular Biology. 19(3). 477–484. 41 indexed citations
6.
Särnstrand, Bengt, Anders Tunek, Karin Sjödin, & Anders Hallberg. (1995). Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats. Chemico-Biological Interactions. 94(2). 157–164. 27 indexed citations
7.
Engman, Lars, Anders Tunek, Mathias Hallberg, & Anders Hallberg. (1994). Catalytic effects of glutathione peroxidase mimetics on the thiol reduction of cytochrome c. Chemico-Biological Interactions. 93(2). 129–137. 20 indexed citations
8.
Piitulainen, Eeva, Anders Tunek, Mikael Larson, et al.. (1993). Airway Inflammation in Smokers with Nonobstructive and Obstructive Chronic Bronchitis. American Review of Respiratory Disease. 148(5). 1226–1230. 149 indexed citations
9.
Tunek, Anders, et al.. (1991). Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEa. Biochemical Pharmacology. 41(3). 345–348. 6 indexed citations
10.
Lindberg, Claes, et al.. (1990). Determination of bambuterol, a prodrug of terbutaline, in plasma and urine by gas chromatography/mass spectrometry. Journal of Mass Spectrometry. 19(4). 218–224. 21 indexed citations
11.
Karg, Eszter, et al.. (1990). Alteration of Glutathione Level in Human Melanoma Cells: Effect of N‐Acetyl‐L‐Cysteine and its Analogues. Pigment Cell Research. 3(1). 11–15. 11 indexed citations
12.
Karg, Eszter, et al.. (1990). Glutathione in human melanoma cells Effects of cysteine, cysteine esters and glutathione isopropyl ester. Journal of Dermatological Science. 1(1). 39–45. 9 indexed citations
13.
Sjödin, Karin, et al.. (1989). Metabolism of N-acetyl-l-cysteine Some structural requirements for the deacetylation and consequences for the oral bioavailability. Biochemical Pharmacology. 38(22). 3981–3985. 90 indexed citations
14.
Tunek, Anders, et al.. (1988). The design and bioactivation of presystemically stable prodrugs. Drug Metabolism Reviews. 19(2). 165–194. 58 indexed citations
15.
Tunek, Anders, et al.. (1988). Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.. Drug Metabolism and Disposition. 16(5). 759–764. 77 indexed citations
16.
Tunek, Anders, et al.. (1988). Hydrolysis of 3H-bambuterol, a carbamate prodrug of terbutaline, in blood from humans and laboratory animals in vitro. Biochemical Pharmacology. 37(20). 3867–3876. 61 indexed citations
17.
Tunek, Anders, Benkt Högstedt, & Tor Olofsson. (1982). Mechanism of benzene toxicity. Effects of benzene and benzene metabolites on bone marrow cellularity, number of granulopoietic stem cells and frequency of micronuclei in mice. Chemico-Biological Interactions. 39(2). 129–138. 63 indexed citations
18.
19.
Tunek, Anders, et al.. (1980). Irreversible Binding of Isolated Benzo[a]pyrene Metabolites to Specific Rat Liver Microsomal Proteins. Molecular Pharmacology. 18(3). 529–535. 16 indexed citations
20.
Berlin, Maths, et al.. (1979). Biological Threshold Limits for Benzene Based on Pharmacokinetics of Inhaled Benzene in Man. Archives of toxicology. Supplement. 305–310. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.P. Witschi Breakdown of academic impact, for papers by K. Sree Kumar Breakdown of academic impact, for papers by Anne P. Autor Breakdown of academic impact, for papers by H Bartsch Breakdown of academic impact, for papers by Manfred Kiese Breakdown of academic impact, for papers by Cheryl L. Zimmerman Breakdown of academic impact, for papers by Shobha A. Akerkar Breakdown of academic impact, for papers by Gisela Witz Breakdown of academic impact, for papers by Cristina Schmitt Gregolin Breakdown of academic impact, for papers by Hiroshi Ohshima
Rankless by CCL
2026